Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs
AIM: To provide an updated picture of the therapies most commonly used in the advanced Non-Small Cell Lung Cancer (NSCLC) setting, together with the relevant costs. METHODS: This study considered the clinical records of patients affected by stage IIIb and IV NSCLC treated in the AORN dei Colli - Ple...
Main Authors: | Francovito Piantedosi, Raffaela Cerisoli, Ciro Battiloro, Francesca Andreozzi, Fabiana Vitiello, Marina Gilli, Valeria De Marino, Antonietta Letizia, Antonella Bianco, Ivana Caprice, Adele Savoia, Adriano Cristinziano, Giorgia Smeraglio, Danilo Rocco |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2019-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1376 |
Similar Items
-
Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients
by: Luigi Della Gravara, et al.
Published: (2021-06-01) -
The Study of NSCLC Cell Response and the Drug-Drug Interaction upon EGFR-TKI Small Molecular Treatment
by: Wang, Hsian-Yu, et al.
Published: (2017) -
Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs
by: [No authors listed]
Published: (2019-06-01) -
Combined treatment with N‐acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line
by: Jun Li, et al.
Published: (2020-02-01) -
AIF gene expression and drug resistance in NSCLC.
by: Wen-Heng Chen, et al.
Published: (2005)